← Back
Data updated: Mar 10, 2026
MSN LABS PVT LTD
Oncology
MSN LABS PVT LTD is a generic drug manufacturer focused on Oncology. Key products include AZACITIDINE.
2022
Since
10
Drugs
-
Trials
64
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LACOSAMIDE 2026-01-29
LACOSAMIDE 2026-01-21
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-09-03
Labeling
LACOSAMIDE 2025-09-03
Labeling
LACOSAMIDE 2025-07-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2022-03-17
- Latest
- 2024-05-16
- Applications
- 14